Laboratorios Farmaceuticos Rovi, S.A.
General ticker "LABFF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $4.6B (TTM average)
Laboratorios Farmaceuticos Rovi, S.A. does not follow the US Stock Market performance with the rate: -35.1%.
Estimated limits based on current volatility of 0.0%: low 67.17$, high 67.17$
Factors to consider:
- Company pays dividends (irregularly): last record date 2026-07-14, amount 1.10$ (Y1.64%)
Short-term LABFF quotes
Long-term LABFF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €829.51MM | €763.75MM | €743.20MM |
| Operating Expenses | €609.25MM | €584.20MM | €570.13MM |
| Operating Income | €220.25MM | €179.54MM | €173.08MM |
| Non-Operating Income | €0.15MM | €-1.85MM | €10.12MM |
| Interest Expense | €0.95MM | €2.43MM | €2.84MM |
| R&D Expense | €25.36MM | €26.19MM | €37.78MM |
| Income(Loss) | €220.41MM | €177.69MM | €183.19MM |
| Taxes | €50.11MM | €40.81MM | €42.88MM |
| Net Income(Loss)* | €170.34MM | €136.88MM | €140.39MM |
| Stockholders Equity | €539.39MM | €572.03MM | €664.17MM |
| Inventory | €337.97MM | €329.95MM | €287.87MM |
| Assets | €799.88MM | €832.02MM | €955.33MM |
| Operating Cash Flow | €113.25MM | €138.28MM | €185.30MM |
| Capital expenditure | €55.19MM | €62.22MM | €65.19MM |
| Investing Cash Flow | €-52.03MM | €-81.06MM | €-67.54MM |
| Financing Cash Flow | €-160.84MM | €-55.36MM | €-47.00MM |
| Earnings Per Share** | €3.20 | €2.67 | €2.74 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.